This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Colitis due to radiation
COLITRAD
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
350 |
4. Check minimum number of eventsNone |
350 |
5. Include endpointsNone |
350 |
6. Filter based on genotype QC (FinnGen only) |
350 |
Control definitions (FinnGen only)
- Control exclude
- K11_ENERCOLNONINF
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- K52
- Name in latin
- Gastroenteritis e radiatione
Similar endpoints
↥List of similar endpoints to
Colitis due to radiation
based on the number of shared cases.
Similar with more cases:
- Other noninfective gastroenteritis and colitis
- Noninfective enteritis and colitis
- Gastrointestinal diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 350 | 108 | 242 |
| Unadjusted period prevalence (%) | 0.09 | 0.04 | 0.11 |
| Median age at first event (years) | 68.70 | 59.70 | 72.72 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 317
- Matched controls
- 3170
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
+∞
323.0
317
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
11.3
78.8
185
348
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
11.5
78.7
182
333
UJF32
NOMESCO Finland
Coloscopy
9.2
70.8
205
525
116
Kela drug reimbursment
Prostate cancer
12.6
69.3
140
187
A07EC02
ATC
mesalazine; oral, rectal
75.0
67.2
75
13
A07EA02
ATC
hydrocortisone; rectal
79.6
57.8
64
10
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
11.3
53.4
110
142
L02AE02
ATC
leuprorelin; implant, parenteral
11.3
49.5
101
126
K62.7
ICD-10 Finland
Radiation proctitis
82.3
44.4
49
7
L02BB03
ATC
bicalutamide; oral
10.9
34.9
70
80
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
8.9
28.7
64
87
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
36.7
28.4
36
11
Y77
ICPC
Malignant neoplasm prostate
9.1
27.7
61
81
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
27.5
26
*
A07EA06
ATC
budesonide; oral, local oral
68.3
27.5
31
5
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
294.5
27.1
27
*
K62.8
ICD-10 Finland
Other specified diseases of anus and rectum
98.0
25.1
27
*
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
270.2
25.0
25
*
J01MA02
ATC
ciprofloxacin; systemic
3.5
25.0
190
945
TKE00
NOMESCO Finland
Needle biopsy of prostate
6.4
22.6
63
118
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
38.2
22.4
28
8
JFA55
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in colon
41.9
22.1
27
7
WF002
NOMESCO Finland
Radical radiotherapy
6.4
21.9
61
114
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
7.8
20.2
48
71
ZX090
NOMESCO Finland
Other technic of radiotherapy
11.8
20.0
37
35
C10AC01
ATC
colestyramine; oral
21.8
19.4
28
14
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
10.1
19.0
38
42
XKD00
NOMESCO Finland
Uroflowmetry
3.1
17.8
123
532
XX3DW
NOMESCO Finland
Time consuming IT work
4.4
17.2
67
181
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.3
16.7
101
394
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
16.5
140
682
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
16.4
190
1121
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.4
16.3
63
168
K51.5
ICD-10 Finland
Left sided colitis
+∞
15.7
15
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.2
15.4
97
386
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
15.2
130
633
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
9.2
14.9
31
37
JN4BD
NOMESCO Finland
Extensive body CT
3.6
14.8
74
248
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.9
13.6
59
174
A06AC01
ATC
ispaghula (psylla seeds); oral
2.8
13.2
105
479
NK6AN
NOMESCO Finland
Total body bone isotope imaging
6.8
13.1
33
53
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
8.8
12.8
27
33
UKC02
NOMESCO Finland
Cystoscopy
2.7
12.8
105
487
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
12.6
124
639
JGA28
NOMESCO Finland
Endoscopic contact coagulation in rectum
+∞
12.6
12
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
8.7
12.3
26
32
ZX070
NOMESCO Finland
Intensity modified radiotherapy
9.3
12.3
25
29
UJF30
NOMESCO Finland
Ileoscopy through colon
4.3
12.0
46
121
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
31.3
11.7
15
5
L02AE03
ATC
goserelin; implant
10.6
11.7
22
22
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
+∞
11.5
11
*
K51.8
ICD-10 Finland
Other ulcerative colitis
+∞
11.5
11
*
128
Kela drug reimbursment
Cancers of female genital organs
11.8
11.2
20
18
C05AA08
ATC
fluocortolone; rectal, topical
3.0
10.9
68
263
XJH00
NOMESCO Finland
Transanal ultrasonography
3.3
10.8
59
207
A07DA03
ATC
loperamide; oral
6.0
10.7
29
52
R31
ICD-10 Finland
Unspecified haematuria
2.9
10.7
71
286
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
10.6
58
203
LCD30
NOMESCO Finland
Radical hysterectomy
+∞
10.5
10
*
K50.8
ICD-10 Finland
Other Crohn disease
+∞
10.5
10
*
N02AX02
ATC
tramadol; systemic, rectal
2.2
10.3
156
966
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.9
10.2
66
261
H02AB06
ATC
prednisolone; systemic
2.2
10.1
163
1036
G03HA01
ATC
cyproterone; systemic
14.0
9.8
16
12
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
7.5
9.7
22
31
ZX080
NOMESCO Finland
Image guided radiotherapy
9.5
9.7
19
21
ZX120
NOMESCO Finland
Intravenous
3.4
9.6
47
153
JGA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in rectum
102.9
9.5
10
*
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
+∞
9.4
9
*
JGA35
NOMESCO Finland
Other endoscopic haemostatic procedure in rectum
+∞
9.4
9
*
K50.9
ICD-10 Finland
Crohn disease, unspecified
+∞
9.4
9
*
G04CA02
ATC
tamsulosin; oral
2.1
9.3
145
899
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
12.0
9.2
16
14
D16
ICPC
Rectal bleeding
6.9
9.1
22
34
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.5
9.1
78
363
WF003
NOMESCO Finland
Adjuvant radiotherapy
5.6
8.8
25
48
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
6.9
8.8
21
32
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
5.0
8.7
27
58
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.1
8.6
148
946
UJG02
NOMESCO Finland
Proctoscopy
7.0
8.5
20
30
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.6
8.5
24
46
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
3.2
8.3
43
146
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
8.1
117
689
L02BX03
ATC
abiraterone; oral
12.1
8.1
14
12
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.2
8.1
92
491
P01AB01
ATC
metronidazole; oral, rectal
2.1
8.0
119
710
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
8.0
145
937
A02BA02
ATC
ranitidine; systemic
2.3
7.9
84
433
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
7.7
57
242
R50.9
ICD-10 Finland
Fever, unspecified
2.6
7.7
57
242
K59.1
ICD-10 Finland
Functional diarrhoea
4.4
7.7
27
66
L04AX01
ATC
azathioprine; systemic
6.0
7.7
20
35
JN4AD
NOMESCO Finland
Body CT examination
3.2
7.6
40
138
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
7.4
7.6
17
24
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.9
7.5
47
181
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
7.5
47
182
J01DB01
ATC
cefalexin; oral
2.1
7.4
251
2035
N02BE01
ATC
paracetamol; systemic, rectal
2.3
7.4
271
2272
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
+∞
7.3
7
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.1
7.2
38
132
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
10.4
7.1
13
13
UJH02
NOMESCO Finland
Anoscopy
4.3
7.1
25
62
A02BC01
ATC
omeprazole; systemic
2.0
7.0
108
645
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.1
7.0
37
128
163
Kela drug reimbursment
Abiraterone and enzalutamide
7.0
6.9
16
24
SPAT1263
SPAT
Sampling
1.9
6.8
141
944
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
5.1
6.8
20
41
J01EA01
ATC
trimethoprim; systemic
2.1
6.7
81
440
352
Kela drug reimbursment
Abiraterone and enzalutamide
9.0
6.6
13
15
H02AB02
ATC
dexamethasone; systemic
2.7
6.6
46
190
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
6.6
48
202
L03AA13
ATC
pegfilgrastim; parenteral
5.2
6.6
19
38
L02BX02
ATC
degarelix; parenteral
6.4
6.5
16
26
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.9
6.5
20
43
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
6.5
34
117
G04BE03
ATC
sildenafil; oral
7.6
6.5
14
19
A02BC02
ATC
pantoprazole; systemic
1.8
6.5
200
1521
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
6.4
53
240
J02AC01
ATC
fluconazole; systemic
2.0
6.4
99
589
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
6.8
6.4
15
23
N02AA05
ATC
oxycodone; systemic
2.2
6.3
67
341
K50.0
ICD-10 Finland
Crohn disease of small intestine
+∞
6.3
6
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
6.3
6
*
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
+∞
6.3
6
*
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
6.3
6
*
K50.1
ICD-10 Finland
Crohn disease of large intestine
+∞
6.3
6
*
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
+∞
6.3
6
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.9
6.2
24
65
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
6.1
106
660
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.4
6.1
51
234
G04BD08
ATC
solifenacin; oral
2.9
6.0
35
129
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
84
178
5.89
39.55
2.2
1.6
—
—
—
0
0
169
786
3.22
25.54
2.9
2.0
3.1
3.1
mg/l
0.12
155
673
215
1237
2.91
20.86
7.6
4.7
33.6
34.5
g/l
1.44
200
1157
69
229
3.51
17.43
2.2
2.1
7.4
11.7
nmol/l
3.11
62
194
190
1113
2.55
16.41
4.1
2.7
187.3
160.9
ug/l
0.28
181
1011
223
1421
2.57
15.90
9.8
6.9
1.2
1.2
mmol/l
0.75
185
1182
233
1518
2.60
15.82
13.1
9.1
4.2
4.3
e9/l
0.19
217
1336
34
72
5.12
15.53
1.5
1.2
—
—
—
0
0
226
1480
2.49
14.72
10.2
6.6
11.0
12.2
umol/l
1.11
221
1397
206
1298
2.43
14.56
9.1
6.1
1.2
1.2
mmol/l
0.34
193
1159
281
2106
2.70
12.65
14.1
7.6
80.7
81.4
u/l
0.09
268
1956
149
870
2.24
11.90
3.3
2.4
57.2
56.9
u/l
0.04
138
805
188
1206
2.21
11.87
2.5
2.1
88.6
91.7
pmol/l
0.47
130
649
92
437
2.50
11.81
3.2
2.6
22.2
22.5
%
0.08
75
373
156
950
2.16
11.01
4.7
3.5
2.3
2.3
mmol/l
0.58
140
816
115
625
2.25
10.74
2.1
1.8
1165.0
1204.3
nmol/l
0.18
98
469
193
1286
2.12
10.65
6.5
4.3
—
—
—
0
0
169
1073
2.11
10.58
4.9
3.4
—
—
—
0
0
26
62
4.45
10.28
1.7
1.4
297.1
288.1
ug/g
0.07
20
34
94
481
2.30
10.05
6.1
3.4
0.8
0.8
mmol/l
1.92
86
448
73
337
2.47
9.81
4.2
4.5
3.2
44.1
ug/l
1.10
63
288
233
1702
2.10
9.65
7.4
4.9
6.9
6.9
mmol/l
0.03
217
1598
129
763
2.09
9.52
1.8
1.6
17.2
19.8
nmol/l
1.39
117
633
27
72
3.98
9.24
1.5
1.2
—
—
—
0
0
27
72
3.98
9.24
1.5
1.2
—
—
—
0
0
78
381
2.35
9.22
9.0
7.1
1.4
1.3
mmol/l
0.11
56
288
156
1003
2.00
9.05
2.7
2.1
72.4
78.5
nmol/l
2.19
144
864
186
1294
1.93
8.37
5.3
3.9
0.0
0.0
estimate
0.00
37
262
98
545
2.11
8.36
2.1
1.8
—
—
—
0
0
251
1946
2.02
8.05
5.7
4.0
17.9
13.8
mm/h
3.06
241
1760
88
495
2.04
7.17
3.6
3.0
1.0
1.1
e6/l
0.07
54
298
183
1309
1.83
7.16
5.4
3.9
0.0
0.0
estimate
0.00
40
248
129
837
1.86
6.84
4.7
3.3
0.4
0.5
e6/l
0.17
102
647
29
101
3.04
6.65
1.5
1.3
—
—
—
0
0
129
848
1.83
6.50
2.3
2.0
181.6
262.4
u/l
1.03
119
788
304
2604
2.27
6.48
32.0
16.8
28.1
27.7
mg/l
0.06
267
2121
106
656
1.88
6.46
3.3
2.4
—
—
—
0
0
84
483
1.97
6.37
3.6
3.2
1.5
1.6
e6/l
0.05
51
291
168
1206
1.76
6.21
4.5
4.1
28.5
49.5
ng/l
2.70
128
927
95
574
1.90
6.20
6.0
4.3
1.0
1.0
kg/l
1.37
16
92
19
53
3.73
6.12
1.6
1.3
—
—
—
0
0
105
658
1.85
6.11
1.9
1.8
402.2
10674595.2
pmol/l
0.50
88
534
176
1289
1.73
5.99
6.5
5.3
0.0
0.0
estimate
0.00
40
262
91
548
1.89
5.98
2.5
1.7
1.8
1.4
mg/l
0.23
71
432
69
378
2.03
5.97
2.0
1.7
—
—
—
0
0
69
381
2.01
5.83
2.2
1.8
—
—
—
0
0
54
276
2.13
5.60
2.8
2.6
5.7
8.7
ug/l
0.92
45
239
79
470
1.88
5.34
1.5
1.2
2.3
1.2
u/ml
0.30
24
113
44
214
2.21
5.16
5.3
3.3
56.1
56.8
ml/min/173m2
0.05
21
95
12
27
4.57
5.07
2.5
2.3
—
—
—
0
0
58
318
1.99
4.97
3.4
3.1
5.3
9.8
umol/l
2.54
49
276
120
826
1.69
4.89
4.8
3.5
31.3
32.3
u/l
0.17
115
785
190
1484
1.61
4.61
10.6
5.5
7.5
3.4
ug/l
0.72
169
1278
197
1560
1.60
4.46
4.6
3.2
50.0
53.7
u/l
0.32
188
1439
11
26
4.34
4.39
1.3
1.1
—
—
—
0
0
263
2241
1.70
4.38
32.5
18.3
35.2
38.9
%
3.82
147
1419
227
1866
1.62
4.34
3.6
3.5
15.0
15.0
pmol/l
0.00
201
1636
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
109
2.50
4.26
3.8
2.3
0.5
0.4
u/ml
0.78
17
57
11
27
4.17
4.19
1.4
1.5
—
—
—
0
0
90
596
1.69
4.15
5.4
3.9
190.2
232.8
ng/l
0.14
81
506
11
28
4.02
4.01
1.4
1.5
—
—
—
0
0
11
28
4.02
4.01
1.4
1.5
—
—
—
0
0
85
560
1.68
3.99
3.9
3.3
2.4
2.4
mmol/l
0.27
74
492
19
71
2.77
3.89
5.7
2.4
3.3
3.7
g/l
0.45
19
66
8
11
7.41
3.88
1.6
1.5
—
—
—
0
0
8
11
7.41
3.88
1.6
1.5
—
—
—
0
0
305
2741
1.88
3.85
37.1
20.2
4.0
4.0
mmol/l
0.24
294
2654
62
378
1.78
3.82
1.4
1.3
25.0
39.7
iu/ml
0.73
23
112
23
96
2.49
3.81
1.1
1.1
—
—
—
0
0
31
149
2.19
3.76
2.1
2.1
3.4
4.1
ug/l
0.09
26
127
59
357
1.78
3.73
1.2
1.3
1.3
14.6
u/ml
2.19
15
125
10
25
4.09
3.72
1.4
1.5
—
—
—
0
0
304
2737
1.84
3.70
36.6
20.0
138.8
139.6
mmol/l
6.69
293
2650
44
244
1.92
3.65
3.6
2.3
35.4
31.6
u/l
0.35
34
207
137
1032
1.54
3.64
3.8
3.2
1857.4
1930.0
ng/l
0.06
122
898
18
68
2.74
3.62
1.8
1.3
—
—
—
0
0
18
68
2.74
3.62
1.8
1.3
—
—
—
0
0
16
57
2.89
3.57
2.2
1.7
—
—
—
0
0
104
746
1.56
3.41
6.4
4.1
0.0
0.0
estimate
0.00
33
244
10
27
3.78
3.38
1.4
1.5
—
—
—
0
0
10
27
3.78
3.38
1.4
1.5
—
—
—
0
0
38
206
1.95
3.37
2.9
3.7
0.6
1.8
mmol/l
0.84
29
157
104
757
1.53
3.16
3.8
3.0
363.7
6080.4
umol/l
2.53
91
637
20
86
2.41
3.14
2.3
2.1
129.4
126.5
g/l
0.15
15
64
132
1012
1.49
3.13
6.2
4.2
—
—
—
0
0
18
74
2.51
3.10
1.8
1.5
—
—
—
0
0
15
56
2.75
3.10
1.8
1.5
—
—
—
0
0
18
75
2.48
3.02
1.8
1.5
—
—
—
0
0
67
446
1.62
2.98
25.3
26.8
1.9
1.4
inr
—
7
50
265
2346
1.53
2.95
4.7
4.4
2.0
2.5
mu/l
0.49
240
2063
14
52
2.76
2.92
1.2
1.2
—
—
—
0
0
47
288
1.73
2.85
5.9
3.9
1.2
1.7
mmol/l
0.17
39
221
309
2844
1.74
2.84
47.0
24.6
124.2
133.9
g/l
19.68
299
2785
309
2844
1.74
2.84
46.7
24.4
4.1
4.4
e12/l
15.66
294
2750
47
290
1.72
2.78
5.8
3.9
5.8
5.7
kpa
0.09
47
277
25
126
2.06
2.73
2.6
3.5
24.3
1280.6
u/ml
0.78
20
109
11
40
2.81
2.39
1.0
1.3
—
—
—
0
0
297
2734
1.57
2.39
17.8
10.8
22.7
24.2
u/l
1.04
287
2611
12
48
2.55
2.21
1.7
1.5
—
—
—
0
0
6
15
4.05
2.04
1.2
1.8
—
—
—
0
0
52
358
1.53
2.01
18.6
8.0
—
—
—
0
0
106
841
1.37
1.94
4.1
3.2
0.8
0.8
ug/l
0.12
74
575
143
1189
1.34
1.93
6.8
4.7
16.7
21.5
%
1.26
69
617
49
337
1.53
1.91
5.0
3.7
—
—
—
0
0
30
184
1.69
1.85
1.8
1.5
—
—
—
0
0
7
23
3.08
1.81
1.0
1.0
—
—
—
0
0
37
242
1.59
1.79
4.2
3.1
4.3
4.4
kpa
0.01
37
230
9
36
2.54
1.75
1.2
1.5
—
—
—
0
0
6
19
3.19
1.67
1.0
1.2
—
—
—
0
0
6
19
3.19
1.67
2.3
1.8
—
—
—
0
0
5
14
3.61
1.62
1.0
1.1
—
—
—
0
0
13
63
2.10
1.62
1.4
1.7
—
—
—
0
0
21
122
1.77
1.58
2.7
3.0
—
—
—
0
0
16
85
1.92
1.57
1.3
1.6
—
—
—
0
0
22
131
1.72
1.53
1.7
1.7
—
—
—
0
0
152
1311
1.28
1.49
3.0
2.6
—
—
—
0
0
14
73
1.96
1.46
1.4
1.4
—
—
—
0
0
11
52
2.15
1.46
1.7
1.5
—
—
—
0
0
7
29
2.44
1.40
2.6
1.5
—
—
—
0
0
7
29
2.44
1.40
2.6
1.5
—
—
—
0
0
7
29
2.44
1.40
2.6
1.5
—
—
—
0
0
232
2123
1.28
1.34
36.6
20.8
14.4
13.9
%
4.99
227
2082
9
44
2.07
1.27
2.2
1.6
—
—
—
0
0
12
63
1.94
1.24
1.1
1.3
—
—
—
0
0
9
45
2.03
1.24
1.2
1.1
—
—
—
0
0
8
37
2.19
1.22
1.1
1.3
—
—
—
0
0
5
19
2.65
1.22
1.2
1.1
—
—
—
0
0
11
57
1.96
1.18
2.1
1.5
—
—
—
0
0
7
30
2.36
1.13
2.6
1.4
—
—
—
0
0
7
30
2.36
1.13
1.3
1.6
—
—
—
0
0
5
21
2.40
1.09
7.6
4.2
—
—
—
0
0
260
2438
1.26
1.09
27.4
16.1
73.9
74.6
ml/min/173m2
0.17
231
2026
10
52
1.95
1.07
2.1
1.6
—
—
—
0
0
41
308
1.38
1.06
1.6
1.4
—
—
—
0
0
7
33
2.14
1.06
2.6
1.4
—
—
—
0
0
7
34
2.08
1.03
1.3
1.3
—
—
—
0
0
14
83
1.72
1.03
1.4
1.7
—
—
—
0
0
9
49
1.86
0.99
2.1
1.6
—
—
—
0
0
27
191
1.45
0.98
2.0
1.6
—
—
—
0
0
7
36
1.96
0.97
5.4
4.0
—
—
—
0
0
9
50
1.82
0.97
1.0
1.2
—
—
—
0
0
28
201
1.43
0.95
5.2
3.2
125.0
126.4
g/l
0.13
28
196
266
2518
1.23
0.92
5.6
4.9
6.1
6.1
mmol/l
0.18
246
2234
23
161
1.46
0.89
5.3
3.4
25.5
24.8
mmol/l
0.22
23
154
6
30
2.02
0.87
2.0
1.5
—
—
—
0
0
106
925
1.21
0.87
4.1
4.1
14.7
11.4
mg/mmol
0.25
81
608
15
96
1.59
0.86
2.4
2.6
24.1
24.4
mmol/l
0.13
15
84
17
117
1.48
0.73
1.4
1.6
—
—
—
0
0
20
143
1.42
0.72
3.0
2.2
—
—
—
0
0
10
61
1.66
0.69
2.0
1.7
—
—
—
0
0
5
28
1.80
0.66
1.0
1.5
—
—
—
0
0
12
78
1.56
0.66
2.8
1.7
—
—
—
0
0
18
129
1.42
0.65
2.8
2.0
—
—
—
0
0
21
156
1.37
0.62
2.8
2.9
1.4
1.1
%
0.37
21
156
9
65
1.39
0.51
1.2
1.5
286.1
260.5
mu/l
—
9
59
42
355
1.21
0.50
4.0
4.9
32.2
31.8
%
0.09
34
229
7
50
1.41
0.45
1.3
1.1
—
—
—
0
0
12
86
1.41
0.45
2.4
2.3
7.8
7.7
kpa
0.02
12
77
5
35
1.43
0.39
2.0
2.6
—
—
—
0
0
9
68
1.33
0.38
1.9
1.6
—
—
—
0
0
9
126
0.71
0.35
1.8
1.7
—
—
—
0
0
6
45
1.34
0.34
1.8
1.3
—
—
—
0
0
7
56
1.26
0.29
1.1
1.2
—
—
—
0
0
21
176
1.21
0.29
2.3
3.3
0.2
0.2
e6/l
0.02
21
170
244
2383
1.08
0.24
4.4
4.2
1.3
1.2
mmol/l
1.45
223
2117
15
124
1.22
0.24
4.5
2.3
—
—
—
0
0
16
134
1.20
0.23
1.1
1.2
25.4
125.7
iu/ml
—
5
48
248
2426
1.08
0.23
7.3
6.4
41.4
41.0
mmol/mol
0.26
233
2210
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
1.2
—
0
7
7
59
1.19
0.18
1.3
1.2
0.7
0.8
nmol/l
—
7
51
260
2563
1.06
0.14
5.6
5.2
2.4
2.5
mmol/l
1.60
243
2285
5
45
1.11
0.10
2.0
1.6
—
—
—
0
0
6
56
1.07
0.08
2.0
1.5
44.2
45.0
nmol/l
—
6
51
251
2487
1.03
0.07
5.0
4.7
4.3
4.4
mmol/l
0.57
236
2241
10
89
1.13
0.07
1.6
1.4
—
—
—
0
0
24
226
1.07
0.07
2.0
1.4
—
—
—
0
0
66
678
0.97
0.06
1.9
1.7
1.4
1.3
mmol/l
0.47
54
544
248
2465
1.02
0.04
4.8
4.6
1.4
1.4
mmol/l
0.18
231
2195
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
15.1
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
0.00
1.0
1.3
14.7
19.8
iu/l
—
5
50
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
1.2
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: COLITRAD – Colitis due to radiation
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).